| 06th week of 2020 patent applcation highlights part 26 |
| Patent application number | Title | Published |
|---|
| 20200040002 | TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS | 2020-02-06 |
| 20200040003 | Compositions and Methods for the Treatment of Xerostomia | 2020-02-06 |
| 20200040004 | RAPAFUCIN DERIVATIVE COMPOUNDS AND METHODS OF USE THEREOF | 2020-02-06 |
| 20200040005 | ANTIBACTERIAL AGENTS AGAINST D,D- AND L,D-TRANSPEPTIDASES | 2020-02-06 |
| 20200040006 | NOVEL COMPOUNDS AS GPR119 AGONISTS | 2020-02-06 |
| 20200040007 | CRYSTALLINE POLYMORPHS OF A MUSCARINIC ACETYLCHOLINE RECEPTOR AGONIST | 2020-02-06 |
| 20200040008 | DIHYDROARTEMISININ DIPLOID DERIVATIVE, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATION | 2020-02-06 |
| 20200040009 | TRICYCLIC HETERARYL COMPOUNDS AS STING ACTIVATORS | 2020-02-06 |
| 20200040010 | NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS | 2020-02-06 |
| 20200040011 | NITROGEN-CONTAINING CYCLIC COMPOUND AND COLOR-CHANGING FILM COMPRISING SAME | 2020-02-06 |
| 20200040012 | HIGHLY REACTIVE METAL HYDRIDES, PROCESS FOR THEIR PREPARATION AND USE | 2020-02-06 |
| 20200040013 | HALOGEN FREE SYNTHESES OF AMINOSILANES BY CATALYTIC DEHYDROGENATIVE COUPLING | 2020-02-06 |
| 20200040014 | THICKENING STABILIZER AND THICKENING STABILIZER COMPOSITION INCLUDING SAME | 2020-02-06 |
| 20200040015 | PRODRUG COMPOSITIONS | 2020-02-06 |
| 20200040016 | FUNCTIONALIZED F-POSS MONOMER COMPOSITIONS AND USES THEREOF | 2020-02-06 |
| 20200040017 | A METHOD FOR MAKING A SOLID-SUPPORTED PHOSPHOLIPID BILAYER | 2020-02-06 |
| 20200040018 | AMINE SYNERGISTS | 2020-02-06 |
| 20200040019 | N-PHOSPHONOXYMETHL PRODRUGS OF HYDROXYALKYL THIADIAZOLE DERIVATIVES | 2020-02-06 |
| 20200040020 | PROCESSES FOR PREPARING OLIGOMERS | 2020-02-06 |
| 20200040021 | CHIRAL METAL COMPLEX COMPOUNDS | 2020-02-06 |
| 20200040022 | METHOD FOR TREATING LIGNIN AND FOR PRODUCING A BINDER COMPOSITION | 2020-02-06 |
| 20200040023 | METHOD FOR PRODUCING ALLULOSE CRYSTALS | 2020-02-06 |
| 20200040024 | CONVERGENT PROCESSES FOR PREPARING MACROLIDE ANTIBACTERIAL AGENTS | 2020-02-06 |
| 20200040025 | URIDINE NUCLEOSIDE DERIVATIVES, COMPOSITIONS AND METHODS OF USE | 2020-02-06 |
| 20200040026 | TRINUCLEOTIDE MRNA CAP ANALOGS | 2020-02-06 |
| 20200040027 | A METHOD FOR THE SITE-SPECIFIC ENZYMATIC LABELLING OF NUCLEIC ACIDS IN VITRO BY INCORPORATION OF UNNATURAL NUCLEOTIDES | 2020-02-06 |
| 20200040028 | CYCLIC DINUCLEOTIDES CONTAINING BENZIMIDAZOLE, METHOD FOR THE PRODUCTION OF SAME, AND USE OF SAME TO ACTIVATE STIMULATOR OF INTERFERON GENES (STING)-DEPENDENT SIGNALING PATHWAYS | 2020-02-06 |
| 20200040029 | PROCESS FOR THE PREPARATION OF 9 BETA,10 ALPHA-PROGESTERONE (RETROPROGESTERONE) | 2020-02-06 |
| 20200040030 | PREPARATION OF HIGH PURITY COLLAGEN PARTICLES AND USES THEREOF | 2020-02-06 |
| 20200040031 | ANTI-BACTERIAL PEPTIDE MACROCYCLES AND USE THEREOF | 2020-02-06 |
| 20200040032 | PEPTIDE MACROCYCLES AND USE THEREOF IN THE TREATMENT OF BACTERIAL INFECTIONS | 2020-02-06 |
| 20200040033 | Epitope Tag and Method for Detection and/or Purification of Tagged Polypeptides | 2020-02-06 |
| 20200040034 | IL-2RBETA BINDING COMPOUNDS | 2020-02-06 |
| 20200040035 | ANTIMICROBIAL PEPTIDE HAVING SYNERGISTIC ANTIBACTERIAL EFFECT WITH ANTIBIOTICS ON MULTIDRUG RESISTANT BACTERIA, AND USE THEREOF | 2020-02-06 |
| 20200040036 | IL-2RGAMMA BINDING COMPOUNDS | 2020-02-06 |
| 20200040037 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | 2020-02-06 |
| 20200040038 | Process of Preparing Guanylate Cyclase C Agonists | 2020-02-06 |
| 20200040039 | PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND | 2020-02-06 |
| 20200040040 | COMPOSITIONS AND METHODS TO INCREASE PRODUCTION | 2020-02-06 |
| 20200040041 | NEPOVIRUS COAT PROTEIN FUSION POLYPEPTIDES AND THEIR USE | 2020-02-06 |
| 20200040042 | CHIMERIC MOLECULES AND USES THEREOF | 2020-02-06 |
| 20200040043 | VMP-LIKE SEQUENCES OF PATHOGENIC BORRELIA SPECIES AND STRAINS | 2020-02-06 |
| 20200040044 | Novel Chimeric Insecticidal Proteins Toxic or Inhibitory to Lepidopteran Pests | 2020-02-06 |
| 20200040045 | CARBOHYDRATE PRODUCING PLANT MATERIAL | 2020-02-06 |
| 20200040046 | CHIMERIC GENE FOR HETEROLOGOUS EXPRESSION WHICH ENCODES FOR PEPTIDES WITH ANTIMICROBIAL ACTIVITY | 2020-02-06 |
| 20200040047 | INTERACTION OF DRAXIN AND Y-NETRINS | 2020-02-06 |
| 20200040048 | PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF | 2020-02-06 |
| 20200040049 | DETERMINANTS OF CANCER RESPONSE TO IMMUNOTHERAPY BY PD-1 BLOCKADE | 2020-02-06 |
| 20200040050 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS | 2020-02-06 |
| 20200040051 | FIBROBLAST GROWTH FACTOR (FGF) 1 WITH MUTATION IN THE HEPARIN BINDING DOMAIN AND METHODS OF USE TO REDUCE BLOOD GLUCOSE | 2020-02-06 |
| 20200040052 | ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF | 2020-02-06 |
| 20200040053 | Ligands Modified by Circular Permutation as Agonists and Antagonists | 2020-02-06 |
| 20200040054 | ERFE FUSION POLYPEPTIDES COMPOSITIONS AND METHODS OF USE | 2020-02-06 |
| 20200040055 | DOSING REGIMEN FOR GP100-SPECIFIC TCR - ANTI-CD3 SCFV FUSION PROTEIN | 2020-02-06 |
| 20200040056 | GENOME-EDITED INVARIANT NATURAL KILLER T (INKT) CELLS FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES | 2020-02-06 |
| 20200040057 | IMMUNOTHERAPY WITH B*07 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS | 2020-02-06 |
| 20200040058 | ROR1-SPECIFIC CHIMERIC ANTIGEN RECEPTORS (CAR) WITH HUMANIZED TARGETING DOMAINS | 2020-02-06 |
| 20200040059 | SECRETABLE VARIANT IMMUNOMODULATORY PROTEINS AND ENGINEERED CELL THERAPY | 2020-02-06 |
| 20200040060 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS | 2020-02-06 |
| 20200040061 | MATERIALS AND METHODS FOR TREATMENT OF EARLY ONSET PARKINSON'S DISEASE (PARK1) AND OTHER SYNUCLEIN, ALPHA (SNCA) GENE RELATED CONDITIONS OR DISORDERS | 2020-02-06 |
| 20200040062 | UTI FUSION PROTEINS | 2020-02-06 |
| 20200040063 | PROCESS OF CLONING AND FURTHER PURIFICATION TO MAKE A RECOMBINANT INTRAVENOUS IMMUNOGLOBULIN | 2020-02-06 |
| 20200040064 | PASSIVE ANTIBODY DEPENDENT CELL-MEDIATED ACTIVATION | 2020-02-06 |
| 20200040065 | BROADLY NEUTRALIZING ANTIBODY TARGETING THE EBOLAVIRUS GLYCOPROTEIN INTERNAL FUSION LOOP | 2020-02-06 |
| 20200040066 | ANTIBODY-MEDIATED NEUTRALIZATION OF MARBURG VIRUS | 2020-02-06 |
| 20200040067 | ANTI-SALMONELLA ANTIBODIES AND USES THEREOF | 2020-02-06 |
| 20200040068 | TREATMENT OF CANCER WITH ANTI-LAP MONOCLONAL ANTIBODIES | 2020-02-06 |
| 20200040069 | MONOCLONAL ANTIBODY AND ANTIGENS FOR DIAGNOSING AND TREATING LUNG DISEASE AND INJURY | 2020-02-06 |
| 20200040070 | ANTI CCL24 (EOTAXIN2) ANTIBODIES FOR USE IN THE TREATMENT OF HEPATIC DISEASES | 2020-02-06 |
| 20200040071 | ANTI-EMAP II ANTIBODY AND USE THEREOF | 2020-02-06 |
| 20200040072 | METHODS OF TREATMENT USING IL-23p19 MONOCLONAL ANTIBODIES | 2020-02-06 |
| 20200040073 | METHODS FOR ADMINISTERING ANTI-IL-5 ANTIBODIES | 2020-02-06 |
| 20200040074 | ANTIBODIES TO IL-6 AND USE THEREOF | 2020-02-06 |
| 20200040075 | V-C-FC-V-C ANTIBODY | 2020-02-06 |
| 20200040076 | COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE | 2020-02-06 |
| 20200040077 | ACTIVITY MODULATOR, MEDICINAL AGENT COMPRISING SAME, USE OF CD300A GENE-DEFICIENT MOUSE, AND ANTI-CD300A ANTIBODY | 2020-02-06 |
| 20200040078 | Use of Combination of Anti-PD-1 Antibody and VEGFR Inhibitor in Preparation of Drug for Treating Cancers | 2020-02-06 |
| 20200040079 | HLA-RESTRICTED VGLL1 PEPTIDES AND USE THEREOF | 2020-02-06 |
| 20200040080 | FUSION PROTEIN FOR RESTORING THE FUNCTIONS OF FAILING IMMUNE CELLS AND APPLICATION THEREOF | 2020-02-06 |
| 20200040081 | Anti-CD112R Compositions and Methods | 2020-02-06 |
| 20200040082 | Anti-TIGIT Antibodies | 2020-02-06 |
| 20200040083 | IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINS | 2020-02-06 |
| 20200040084 | COMPOSITIONS AND METHODS RELATED TO ENGINEERED FC-ANTIGEN BINDING DOMAIN CONSTRUCTS | 2020-02-06 |
| 20200040085 | ANTI-HLA-DQ2.5/8 ANTIBODY AND ITS USE FOR THE TREATMENT OF CELIAC DISEASE | 2020-02-06 |
| 20200040086 | PHARMACEUTICAL COMBINATIONS COMPRISING AN ANTI-LY75 ANTIBODY | 2020-02-06 |
| 20200040087 | HUMAN ANTIBODIES TO GFR ALPHA 3 AND METHODS OF USE THEREOF | 2020-02-06 |
| 20200040088 | THERAPEUTIC OR PROPHYLACTIC AGENT AND TREATMENT OR PREVENTION METHOD FOR RADIATION DAMAGE | 2020-02-06 |
| 20200040089 | ANTI-CXCR2 ANTIBODIES AND USES THEREOF | 2020-02-06 |
| 20200040090 | ANTI-CD40 ANTIBODIES | 2020-02-06 |
| 20200040091 | Anti-Human CD52 Immunoglobulins | 2020-02-06 |
| 20200040092 | ANTIBODIES SPECIFIC TO HUMAN POLIOVIRUS RECEPTOR (PVR) | 2020-02-06 |
| 20200040093 | COMPOSITIONS AND METHODS FOR NON-MYELOABLATIVE CONDITIONING | 2020-02-06 |
| 20200040094 | INTERNALIZING HUMAN MONOCLONAL ANTIBODIES TARGETING PROSTATE AND OTHER CANCER CELLS | 2020-02-06 |
| 20200040095 | Immunologic Treatment of Cancer | 2020-02-06 |
| 20200040096 | CHIMERIC ANTIGEN RECEPTORS (CARs) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USE | 2020-02-06 |
| 20200040097 | ANTIBODY AND ANTIGEN RECOGNIZING TUMOR-INITIATING CELLS AND USE THEREOF | 2020-02-06 |
| 20200040098 | ANTI-PD-1 ANTIBODIES AND THEIR USES | 2020-02-06 |
| 20200040099 | Single chain binding molecules comprising N-terminal ABP | 2020-02-06 |
| 20200040100 | MULTIMODAL CANCER THERAPY COMPRISING CHIMERIC VIRAL/NONVIRAL NANOPARTICLES AND ANTICANCER AGENTS | 2020-02-06 |
| 20200040101 | NOVEL ANTIBODIES AND METHODS FOR MAKING AND USING THE SAME | 2020-02-06 |
